These observations could be explained by an inhibitory effect of RB on histone demethylation by KDM5A, either in a direct or indirect manner, and highlight the therapeutic promise of inhibiting KDM5 demethylases, e.g., in RB-deficient cancers. The gene discussed is KDM5A; the disease is cancer.